tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksTop Gainers/ Losers/ Active StocksMost Visited WebsitesDividend StocksChatGPT StocksLargest Companies by Market Cap
ETFs
Top ETFs by Upside
New
Top ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
New
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Stock ScreenerETF Screener
Popular
Trending StocksDaily Analyst RatingsCompare StocksCompare ETFsPenny Stock ScreenerTechnical Analysis ScreenerDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Personal Finance CenterMortgagesLoansInvesting & RetirementSpending & Savings
Calculators
401k Retirement CalculatorMortgage Calculator
Popular
Compound Interest CalculatorDollar Cost Averaging
New
Student Loan CalculatorAuto Loan Calculator
Education
How To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksTipRanks CommunityContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsTop Online BrokersBecome an Affiliate
Follow Us
NewsSmart PortfolioExpert CenterTipRanksAI
TOOLS
My Portfolio
My Watchlist
Earnings Calendar
Stock Screener
Penny Stocks
Top Stocks
Daily Analyst Ratings
STOCKS
BABA
AAPL
SPY
AMZN
QQQ
TSLA
NVDA
ADVANCED RESEARCH
TipRanks Premium
Invest Like a Pro with Unique Data & Simplifed ToolsTry Now
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Top Gainers/ Losers/ Active Stocks
Most Visited Websites
Dividend Stocks
ChatGPT Stocks
Largest Companies by Market Cap
ETFs
ETF Center
Top ETFs by Upside
New
Top ETFs by Smart Score
Top Gainers/ Losers/ Active ETFs
Options
Options Market Overview
Unusual Options Activity
Popular
Most Active Options
Options Volume Leaders
Commodities
Gold
New
Crypto
Crypto Center
Bitcoin
Popular
Ethereum
Currency
Currency Center
EUR/USD
Research Tools
Stock Screener
ETF Screener
Popular
Trending Stocks
Daily Analyst Ratings
Compare Stocks
Compare ETFs
Penny Stock Screener
Technical Analysis Screener
Daily Insider Trading Tracker
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Economic Indicators
Economic Indicators Center
Inflation Rate
Unemployment Rate
Federal Funds Rate
Calculators
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Dollar Cost Averaging
New
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
News
Portfolio
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Calculators
Compound Interest Calculator
New
Mortgage Calculator
Popular
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
TipRanks Community
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
Follow Us

QURE Stock Latest News

Cantor Fitzgerald biotech analyst holds an analyst/industry conference call
The FlyCantor Fitzgerald biotech analyst holds an analyst/industry conference call
24d ago
PTCT
QURE
Cantor Fitzgerald biotech analyst holds an analyst/industry conference call
PremiumThe Fly
Cantor Fitzgerald biotech analyst holds an analyst/industry conference call
25d ago
PTCT
QURE
Cantor Fitzgerald biotech analyst holds an analyst/industry conference call
PremiumThe Fly
Cantor Fitzgerald biotech analyst holds an analyst/industry conference call
28d ago
PTCT
QURE
uniQure price target lowered to $7 from $10 at Mizuho
PremiumThe Fly
uniQure price target lowered to $7 from $10 at Mizuho
2M ago
QURE
uniQure price target lowered to $25 from $30 at H.C. Wainwright
PremiumThe Fly
uniQure price target lowered to $25 from $30 at H.C. Wainwright
2M ago
QURE
Snowflake downgraded and upgraded: Wall Street’s top analyst calls
PremiumThe FlySnowflake downgraded and upgraded: Wall Street’s top analyst calls
2M ago
M
AN
Goldman downgrades uniQure on uncertain path in Huntington’s
PremiumThe Fly
Goldman downgrades uniQure on uncertain path in Huntington’s
2M ago
QURE
uniQure downgraded to Neutral from Buy at Goldman Sachs
PremiumThe Fly
uniQure downgraded to Neutral from Buy at Goldman Sachs
2M ago
QURE
A New Cause for Concern: uniQure N.V. Adds a New Innovation / R&D Risk
PremiumCompany Announcements
A New Cause for Concern: uniQure N.V. Adds a New Innovation / R&D Risk
2M ago
QURE
uniQure reports FY23 EPS ($6.47), consensus ($6.31)
PremiumThe Fly
uniQure reports FY23 EPS ($6.47), consensus ($6.31)
2M ago
QURE
uniQure Announces 2023 Financial Results and Highlights Recent Company Progress
PremiumPress Releases
uniQure Announces 2023 Financial Results and Highlights Recent Company Progress
2M ago
QURE
QURE Earnings this Week: How Will it Perform?
PremiumPre-Earnings
QURE Earnings this Week: How Will it Perform?
2M ago
QURE
uniQure announces update on Phase I/II trials of AMT-130 gene therapy
PremiumThe FlyuniQure announces update on Phase I/II trials of AMT-130 gene therapy
4M ago
QURE
uniQure Announces Update on Phase I/II Clinical Trials of AMT-130 Gene Therapy for the Treatment of Huntington’s Disease
PremiumPress Releases
uniQure Announces Update on Phase I/II Clinical Trials of AMT-130 Gene Therapy for the Treatment of Huntington’s Disease
4M ago
QURE
uniQure downgraded to Neutral from Buy at Mizuho
PremiumThe Fly
uniQure downgraded to Neutral from Buy at Mizuho
4M ago
QURE
uniQure Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
PremiumPress Releases
uniQure Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
4M ago
QURE
uniQure announces inducement grants under Nasdaq listing rule
PremiumThe Fly
uniQure announces inducement grants under Nasdaq listing rule
4M ago
QURE
uniQure Announces FDA Clearance of Investigational New Drug Application for AMT-191 Gene Therapy for Fabry Disease
PremiumPress Releases
uniQure Announces FDA Clearance of Investigational New Drug Application for AMT-191 Gene Therapy for Fabry Disease
5M ago
QURE
uniQure announces FDA clearance of IND application for AMT-191 gene therapy
PremiumThe Fly
uniQure announces FDA clearance of IND application for AMT-191 gene therapy
5M ago
QURE
uniQure expects cash to fund operations into 2Q27
PremiumThe FlyuniQure expects cash to fund operations into 2Q27
5M ago
QURE
uniQure reports Q3 EPS ($1.88), consensus (85c)
PremiumThe Fly
uniQure reports Q3 EPS ($1.88), consensus (85c)
5M ago
QURE
uniQure Announces Third Quarter 2023 Financial Results and Highlights Recent Company Progress
PremiumPress Releases
uniQure Announces Third Quarter 2023 Financial Results and Highlights Recent Company Progress
5M ago
QURE

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >